Insurers Remain Skeptical Of Public Plan As Sen. Schumer Rolls Out Proposal
Executive Summary
Representatives of the insurance industry and big business remained skeptical about the feasibility and fairness of a public insurance option competing with private plans during a Senate Finance Committee roundtable discussion May 5
You may also be interested in...
Pharma Cost-Saving Options Take Backseat In Senate Reform Roundtable
Proposals to pay for an expansion of health care coverage that would directly affect pharmaceuticals took a backseat to tax-related options during the Senate Finance Committee's May 12 roundtable discussion on financing health care reform
Pharma Cost-Saving Options Take Backseat In Senate Reform Roundtable
Proposals to pay for an expansion of health care coverage that would directly affect pharmaceuticals took a backseat to tax-related options during the Senate Finance Committee's May 12 roundtable discussion on financing health care reform
Pharma Share Of Health Reform Cost Savings To Come From Drug Access, Compliance, Personalized Medicine
As stakeholders pledge to reduce health system growth by $2 trillion over 10 years, Rep. Dingell urges support for public plan; Sen. Grassley wants more “concrete” proposals, CBO score.